mirror of
https://github.com/italia/covid19-opendata-vaccini
synced 2024-11-24 13:27:26 +01:00
40 KiB
40 KiB
| 1 | data | forn | area | eta | m | f | d1 | d2 | dpi | db1 | db2 | db3 | N1 | N2 | ISTAT | reg |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 2020-12-27 | Moderna | LAZ | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 3 | 2020-12-27 | Moderna | SIC | 90+ | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 4 | 2020-12-27 | Pfizer/BioNTech | ABR | 20-29 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
| 5 | 2020-12-27 | Pfizer/BioNTech | ABR | 30-39 | 1.0 | 4.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
| 6 | 2020-12-27 | Pfizer/BioNTech | ABR | 40-49 | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
| 7 | 2020-12-27 | Pfizer/BioNTech | ABR | 50-59 | 7.0 | 6.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
| 8 | 2020-12-27 | Pfizer/BioNTech | ABR | 60-69 | 12.0 | 4.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
| 9 | 2020-12-27 | Pfizer/BioNTech | ABR | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
| 10 | 2020-12-27 | Pfizer/BioNTech | ABR | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF1 | 13.0 | Abruzzo |
| 11 | 2020-12-27 | Pfizer/BioNTech | BAS | 20-29 | 4.0 | 5.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
| 12 | 2020-12-27 | Pfizer/BioNTech | BAS | 30-39 | 10.0 | 18.0 | 28.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
| 13 | 2020-12-27 | Pfizer/BioNTech | BAS | 40-49 | 7.0 | 24.0 | 31.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
| 14 | 2020-12-27 | Pfizer/BioNTech | BAS | 50-59 | 11.0 | 15.0 | 26.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
| 15 | 2020-12-27 | Pfizer/BioNTech | BAS | 60-69 | 9.0 | 4.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF5 | 17.0 | Basilicata |
| 16 | 2020-12-27 | Pfizer/BioNTech | CAL | 20-29 | 18.0 | 42.0 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 17 | 2020-12-27 | Pfizer/BioNTech | CAL | 30-39 | 25.0 | 25.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 18 | 2020-12-27 | Pfizer/BioNTech | CAL | 40-49 | 25.0 | 32.0 | 57.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 19 | 2020-12-27 | Pfizer/BioNTech | CAL | 50-59 | 57.0 | 31.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 20 | 2020-12-27 | Pfizer/BioNTech | CAL | 60-69 | 46.0 | 18.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 21 | 2020-12-27 | Pfizer/BioNTech | CAM | 20-29 | 27.0 | 33.0 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 22 | 2020-12-27 | Pfizer/BioNTech | CAM | 30-39 | 61.0 | 64.0 | 125.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 23 | 2020-12-27 | Pfizer/BioNTech | CAM | 40-49 | 80.0 | 87.0 | 167.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 24 | 2020-12-27 | Pfizer/BioNTech | CAM | 50-59 | 119.0 | 77.0 | 196.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 25 | 2020-12-27 | Pfizer/BioNTech | CAM | 60-69 | 131.0 | 37.0 | 167.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 26 | 2020-12-27 | Pfizer/BioNTech | CAM | 70-79 | 5.0 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 27 | 2020-12-27 | Pfizer/BioNTech | EMR | 20-29 | 53.0 | 86.0 | 139.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 28 | 2020-12-27 | Pfizer/BioNTech | EMR | 30-39 | 58.0 | 83.0 | 141.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 29 | 2020-12-27 | Pfizer/BioNTech | EMR | 40-49 | 80.0 | 148.0 | 228.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 30 | 2020-12-27 | Pfizer/BioNTech | EMR | 50-59 | 71.0 | 217.0 | 288.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 31 | 2020-12-27 | Pfizer/BioNTech | EMR | 60-69 | 100.0 | 51.0 | 151.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 32 | 2020-12-27 | Pfizer/BioNTech | EMR | 70-79 | 10.0 | 3.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 33 | 2020-12-27 | Pfizer/BioNTech | EMR | 80-89 | 2.0 | 6.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 34 | 2020-12-27 | Pfizer/BioNTech | EMR | 90+ | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 35 | 2020-12-27 | Pfizer/BioNTech | FVG | 20-29 | 1.0 | 4.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 36 | 2020-12-27 | Pfizer/BioNTech | FVG | 30-39 | 9.0 | 7.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 37 | 2020-12-27 | Pfizer/BioNTech | FVG | 40-49 | 17.0 | 33.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 38 | 2020-12-27 | Pfizer/BioNTech | FVG | 50-59 | 59.0 | 46.0 | 105.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 39 | 2020-12-27 | Pfizer/BioNTech | FVG | 60-69 | 62.0 | 23.0 | 85.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 40 | 2020-12-27 | Pfizer/BioNTech | FVG | 70-79 | 3.0 | 2.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 41 | 2020-12-27 | Pfizer/BioNTech | LAZ | 20-29 | 32.0 | 32.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 42 | 2020-12-27 | Pfizer/BioNTech | LAZ | 30-39 | 39.0 | 41.0 | 80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 43 | 2020-12-27 | Pfizer/BioNTech | LAZ | 40-49 | 20.0 | 33.0 | 52.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 44 | 2020-12-27 | Pfizer/BioNTech | LAZ | 50-59 | 26.0 | 30.0 | 56.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 45 | 2020-12-27 | Pfizer/BioNTech | LAZ | 60-69 | 16.0 | 8.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 46 | 2020-12-27 | Pfizer/BioNTech | LIG | 20-29 | 6.0 | 3.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 47 | 2020-12-27 | Pfizer/BioNTech | LIG | 30-39 | 10.0 | 14.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 48 | 2020-12-27 | Pfizer/BioNTech | LIG | 40-49 | 6.0 | 14.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 49 | 2020-12-27 | Pfizer/BioNTech | LIG | 50-59 | 16.0 | 19.0 | 35.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 50 | 2020-12-27 | Pfizer/BioNTech | LIG | 60-69 | 13.0 | 4.0 | 16.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 51 | 2020-12-27 | Pfizer/BioNTech | LIG | 70-79 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 52 | 2020-12-27 | Pfizer/BioNTech | LIG | 80-89 | 2.0 | 10.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 53 | 2020-12-27 | Pfizer/BioNTech | LIG | 90+ | 1.0 | 12.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 54 | 2020-12-27 | Pfizer/BioNTech | LOM | 20-29 | 20.0 | 22.0 | 42.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 55 | 2020-12-27 | Pfizer/BioNTech | LOM | 30-39 | 31.0 | 33.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 56 | 2020-12-27 | Pfizer/BioNTech | LOM | 40-49 | 62.0 | 81.0 | 142.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 57 | 2020-12-27 | Pfizer/BioNTech | LOM | 50-59 | 115.0 | 119.0 | 234.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 58 | 2020-12-27 | Pfizer/BioNTech | LOM | 60-69 | 160.0 | 41.0 | 201.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 59 | 2020-12-27 | Pfizer/BioNTech | LOM | 70-79 | 21.0 | 2.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 60 | 2020-12-27 | Pfizer/BioNTech | LOM | 80-89 | 4.0 | 6.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 61 | 2020-12-27 | Pfizer/BioNTech | LOM | 90+ | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 62 | 2020-12-27 | Pfizer/BioNTech | MAR | 30-39 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 63 | 2020-12-27 | Pfizer/BioNTech | MAR | 40-49 | 3.0 | 8.0 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 64 | 2020-12-27 | Pfizer/BioNTech | MAR | 50-59 | 8.0 | 15.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 65 | 2020-12-27 | Pfizer/BioNTech | MAR | 60-69 | 9.0 | 4.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 66 | 2020-12-27 | Pfizer/BioNTech | MAR | 70-79 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 67 | 2020-12-27 | Pfizer/BioNTech | MAR | 80-89 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 68 | 2020-12-27 | Pfizer/BioNTech | MAR | 90+ | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 69 | 2020-12-27 | Pfizer/BioNTech | MOL | 20-29 | 0.0 | 4.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 70 | 2020-12-27 | Pfizer/BioNTech | MOL | 30-39 | 4.0 | 5.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 71 | 2020-12-27 | Pfizer/BioNTech | MOL | 40-49 | 4.0 | 3.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 72 | 2020-12-27 | Pfizer/BioNTech | MOL | 50-59 | 5.0 | 5.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 73 | 2020-12-27 | Pfizer/BioNTech | MOL | 60-69 | 4.0 | 0.0 | 3.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 74 | 2020-12-27 | Pfizer/BioNTech | MOL | 70-79 | 1.0 | 3.0 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 75 | 2020-12-27 | Pfizer/BioNTech | MOL | 80-89 | 0.0 | 6.0 | 5.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 76 | 2020-12-27 | Pfizer/BioNTech | MOL | 90+ | 2.0 | 4.0 | 4.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITF | ITF2 | 14.0 | Molise |
| 77 | 2020-12-27 | Pfizer/BioNTech | PAB | 20-29 | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 78 | 2020-12-27 | Pfizer/BioNTech | PAB | 30-39 | 10.0 | 10.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 79 | 2020-12-27 | Pfizer/BioNTech | PAB | 40-49 | 18.0 | 28.0 | 46.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 80 | 2020-12-27 | Pfizer/BioNTech | PAB | 50-59 | 26.0 | 28.0 | 54.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 81 | 2020-12-27 | Pfizer/BioNTech | PAB | 60-69 | 9.0 | 7.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 82 | 2020-12-27 | Pfizer/BioNTech | PAB | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 83 | 2020-12-27 | Pfizer/BioNTech | PAB | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 84 | 2020-12-27 | Pfizer/BioNTech | PAT | 20-29 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 85 | 2020-12-27 | Pfizer/BioNTech | PAT | 30-39 | 2.0 | 7.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 86 | 2020-12-27 | Pfizer/BioNTech | PAT | 40-49 | 8.0 | 17.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 87 | 2020-12-27 | Pfizer/BioNTech | PAT | 50-59 | 10.0 | 19.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 88 | 2020-12-27 | Pfizer/BioNTech | PAT | 60-69 | 16.0 | 6.0 | 22.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 89 | 2020-12-27 | Pfizer/BioNTech | PAT | 70-79 | 3.0 | 1.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 90 | 2020-12-27 | Pfizer/BioNTech | PAT | 80-89 | 1.0 | 7.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 91 | 2020-12-27 | Pfizer/BioNTech | PAT | 90+ | 1.0 | 5.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 92 | 2020-12-27 | Pfizer/BioNTech | PIE | 20-29 | 25.0 | 63.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 93 | 2020-12-27 | Pfizer/BioNTech | PIE | 30-39 | 61.0 | 85.0 | 146.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 94 | 2020-12-27 | Pfizer/BioNTech | PIE | 40-49 | 68.0 | 135.0 | 203.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 95 | 2020-12-27 | Pfizer/BioNTech | PIE | 50-59 | 105.0 | 191.0 | 294.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 96 | 2020-12-27 | Pfizer/BioNTech | PIE | 60-69 | 94.0 | 37.0 | 131.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 97 | 2020-12-27 | Pfizer/BioNTech | PIE | 70-79 | 9.0 | 10.0 | 19.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 98 | 2020-12-27 | Pfizer/BioNTech | PIE | 80-89 | 5.0 | 19.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 99 | 2020-12-27 | Pfizer/BioNTech | PIE | 90+ | 5.0 | 15.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 100 | 2020-12-27 | Pfizer/BioNTech | PUG | 20-29 | 18.0 | 34.0 | 52.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 101 | 2020-12-27 | Pfizer/BioNTech | PUG | 30-39 | 32.0 | 54.0 | 86.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 102 | 2020-12-27 | Pfizer/BioNTech | PUG | 40-49 | 35.0 | 43.0 | 78.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 103 | 2020-12-27 | Pfizer/BioNTech | PUG | 50-59 | 69.0 | 62.0 | 131.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 104 | 2020-12-27 | Pfizer/BioNTech | PUG | 60-69 | 80.0 | 20.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 105 | 2020-12-27 | Pfizer/BioNTech | PUG | 70-79 | 9.0 | 8.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 106 | 2020-12-27 | Pfizer/BioNTech | PUG | 80-89 | 6.0 | 23.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 107 | 2020-12-27 | Pfizer/BioNTech | PUG | 90+ | 3.0 | 14.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 108 | 2020-12-27 | Pfizer/BioNTech | SAR | 20-29 | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 109 | 2020-12-27 | Pfizer/BioNTech | SAR | 30-39 | 0.0 | 3.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 110 | 2020-12-27 | Pfizer/BioNTech | SAR | 40-49 | 3.0 | 7.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 111 | 2020-12-27 | Pfizer/BioNTech | SAR | 50-59 | 12.0 | 8.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 112 | 2020-12-27 | Pfizer/BioNTech | SAR | 60-69 | 21.0 | 8.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 113 | 2020-12-27 | Pfizer/BioNTech | SAR | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 114 | 2020-12-27 | Pfizer/BioNTech | SIC | 20-29 | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 115 | 2020-12-27 | Pfizer/BioNTech | SIC | 30-39 | 7.0 | 9.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 116 | 2020-12-27 | Pfizer/BioNTech | SIC | 40-49 | 16.0 | 9.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 117 | 2020-12-27 | Pfizer/BioNTech | SIC | 50-59 | 22.0 | 8.0 | 30.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 118 | 2020-12-27 | Pfizer/BioNTech | SIC | 60-69 | 38.0 | 10.0 | 48.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 119 | 2020-12-27 | Pfizer/BioNTech | SIC | 70-79 | 10.0 | 4.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 120 | 2020-12-27 | Pfizer/BioNTech | SIC | 80-89 | 2.0 | 7.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 121 | 2020-12-27 | Pfizer/BioNTech | SIC | 90+ | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 122 | 2020-12-27 | Pfizer/BioNTech | TOS | 20-29 | 21.0 | 29.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 123 | 2020-12-27 | Pfizer/BioNTech | TOS | 30-39 | 51.0 | 64.0 | 115.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 124 | 2020-12-27 | Pfizer/BioNTech | TOS | 40-49 | 53.0 | 99.0 | 152.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 125 | 2020-12-27 | Pfizer/BioNTech | TOS | 50-59 | 73.0 | 114.0 | 187.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 126 | 2020-12-27 | Pfizer/BioNTech | TOS | 60-69 | 67.0 | 41.0 | 107.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 127 | 2020-12-27 | Pfizer/BioNTech | TOS | 70-79 | 8.0 | 1.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 128 | 2020-12-27 | Pfizer/BioNTech | TOS | 80-89 | 2.0 | 1.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 129 | 2020-12-27 | Pfizer/BioNTech | TOS | 90+ | 0.0 | 5.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 130 | 2020-12-27 | Pfizer/BioNTech | UMB | 20-29 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 131 | 2020-12-27 | Pfizer/BioNTech | UMB | 30-39 | 8.0 | 2.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 132 | 2020-12-27 | Pfizer/BioNTech | UMB | 40-49 | 4.0 | 10.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 133 | 2020-12-27 | Pfizer/BioNTech | UMB | 50-59 | 10.0 | 15.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 134 | 2020-12-27 | Pfizer/BioNTech | UMB | 60-69 | 24.0 | 6.0 | 30.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 135 | 2020-12-27 | Pfizer/BioNTech | UMB | 70-79 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 136 | 2020-12-27 | Pfizer/BioNTech | UMB | 80-89 | 1.0 | 5.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 137 | 2020-12-27 | Pfizer/BioNTech | UMB | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 138 | 2020-12-27 | Pfizer/BioNTech | VDA | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 139 | 2020-12-27 | Pfizer/BioNTech | VDA | 30-39 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 140 | 2020-12-27 | Pfizer/BioNTech | VDA | 40-49 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 141 | 2020-12-27 | Pfizer/BioNTech | VDA | 50-59 | 4.0 | 5.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 142 | 2020-12-27 | Pfizer/BioNTech | VDA | 60-69 | 3.0 | 2.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 143 | 2020-12-27 | Pfizer/BioNTech | VEN | 20-29 | 22.0 | 52.0 | 66.0 | 0.0 | 8.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 144 | 2020-12-27 | Pfizer/BioNTech | VEN | 30-39 | 62.0 | 57.0 | 117.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 145 | 2020-12-27 | Pfizer/BioNTech | VEN | 40-49 | 51.0 | 104.0 | 155.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 146 | 2020-12-27 | Pfizer/BioNTech | VEN | 50-59 | 121.0 | 217.0 | 336.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 147 | 2020-12-27 | Pfizer/BioNTech | VEN | 60-69 | 133.0 | 51.0 | 182.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 148 | 2020-12-27 | Pfizer/BioNTech | VEN | 70-79 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 149 | 2020-12-28 | Moderna | FVG | 30-39 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 150 | 2020-12-28 | Moderna | LAZ | 20-29 | 1.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 151 | 2020-12-28 | Moderna | LAZ | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 152 | 2020-12-28 | Pfizer/BioNTech | CAL | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 153 | 2020-12-28 | Pfizer/BioNTech | CAL | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 154 | 2020-12-28 | Pfizer/BioNTech | CAL | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 155 | 2020-12-28 | Pfizer/BioNTech | CAL | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 156 | 2020-12-28 | Pfizer/BioNTech | CAL | 60-69 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF6 | 18.0 | Calabria |
| 157 | 2020-12-28 | Pfizer/BioNTech | EMR | 40-49 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 158 | 2020-12-28 | Pfizer/BioNTech | LAZ | 20-29 | 58.0 | 67.0 | 125.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 159 | 2020-12-28 | Pfizer/BioNTech | LAZ | 30-39 | 86.0 | 89.0 | 175.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 160 | 2020-12-28 | Pfizer/BioNTech | LAZ | 40-49 | 63.0 | 175.0 | 238.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 161 | 2020-12-28 | Pfizer/BioNTech | LAZ | 50-59 | 110.0 | 173.0 | 283.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 162 | 2020-12-28 | Pfizer/BioNTech | LAZ | 60-69 | 97.0 | 47.0 | 144.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 163 | 2020-12-28 | Pfizer/BioNTech | LIG | 20-29 | 1.0 | 4.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 164 | 2020-12-28 | Pfizer/BioNTech | LIG | 30-39 | 4.0 | 9.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 165 | 2020-12-28 | Pfizer/BioNTech | LIG | 40-49 | 9.0 | 14.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 166 | 2020-12-28 | Pfizer/BioNTech | LIG | 50-59 | 10.0 | 19.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 167 | 2020-12-28 | Pfizer/BioNTech | LIG | 60-69 | 5.0 | 5.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 168 | 2020-12-28 | Pfizer/BioNTech | LIG | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 169 | 2020-12-28 | Pfizer/BioNTech | LOM | 20-29 | 3.0 | 4.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 170 | 2020-12-28 | Pfizer/BioNTech | LOM | 30-39 | 9.0 | 11.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 171 | 2020-12-28 | Pfizer/BioNTech | LOM | 40-49 | 9.0 | 20.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 172 | 2020-12-28 | Pfizer/BioNTech | LOM | 50-59 | 18.0 | 20.0 | 38.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 173 | 2020-12-28 | Pfizer/BioNTech | LOM | 60-69 | 8.0 | 6.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 174 | 2020-12-28 | Pfizer/BioNTech | SAR | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 175 | 2020-12-28 | Pfizer/BioNTech | SAR | 30-39 | 4.0 | 2.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 176 | 2020-12-28 | Pfizer/BioNTech | SAR | 40-49 | 8.0 | 12.0 | 19.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 177 | 2020-12-28 | Pfizer/BioNTech | SAR | 50-59 | 9.0 | 15.0 | 24.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 178 | 2020-12-28 | Pfizer/BioNTech | SAR | 60-69 | 6.0 | 12.0 | 18.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 179 | 2020-12-28 | Pfizer/BioNTech | SIC | 20-29 | 17.0 | 17.0 | 34.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 180 | 2020-12-28 | Pfizer/BioNTech | SIC | 30-39 | 36.0 | 24.0 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 181 | 2020-12-28 | Pfizer/BioNTech | SIC | 40-49 | 29.0 | 29.0 | 58.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 182 | 2020-12-28 | Pfizer/BioNTech | SIC | 50-59 | 37.0 | 16.0 | 53.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 183 | 2020-12-28 | Pfizer/BioNTech | SIC | 60-69 | 46.0 | 18.0 | 64.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 184 | 2020-12-28 | Pfizer/BioNTech | SIC | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 185 | 2020-12-28 | Pfizer/BioNTech | TOS | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 186 | 2020-12-29 | Moderna | FVG | 30-39 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 187 | 2020-12-29 | Moderna | LAZ | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 188 | 2020-12-29 | Moderna | LAZ | 40-49 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 189 | 2020-12-29 | Moderna | LAZ | 50-59 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 190 | 2020-12-29 | Pfizer/BioNTech | LAZ | 20-29 | 9.0 | 41.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 191 | 2020-12-29 | Pfizer/BioNTech | LAZ | 30-39 | 31.0 | 49.0 | 80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 192 | 2020-12-29 | Pfizer/BioNTech | LAZ | 40-49 | 26.0 | 76.0 | 102.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 193 | 2020-12-29 | Pfizer/BioNTech | LAZ | 50-59 | 60.0 | 121.0 | 181.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 194 | 2020-12-29 | Pfizer/BioNTech | LAZ | 60-69 | 58.0 | 30.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 195 | 2020-12-29 | Pfizer/BioNTech | LAZ | 70-79 | 3.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 196 | 2020-12-29 | Pfizer/BioNTech | LIG | 20-29 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 197 | 2020-12-29 | Pfizer/BioNTech | LIG | 30-39 | 9.0 | 19.0 | 28.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 198 | 2020-12-29 | Pfizer/BioNTech | LIG | 40-49 | 5.0 | 18.0 | 23.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 199 | 2020-12-29 | Pfizer/BioNTech | LIG | 50-59 | 8.0 | 29.0 | 37.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 200 | 2020-12-29 | Pfizer/BioNTech | LIG | 60-69 | 6.0 | 6.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 201 | 2020-12-29 | Pfizer/BioNTech | LIG | 70-79 | 2.0 | 3.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 202 | 2020-12-29 | Pfizer/BioNTech | LIG | 80-89 | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 203 | 2020-12-29 | Pfizer/BioNTech | LIG | 90+ | 1.0 | 8.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 204 | 2020-12-29 | Pfizer/BioNTech | LOM | 20-29 | 2.0 | 9.0 | 11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 205 | 2020-12-29 | Pfizer/BioNTech | LOM | 30-39 | 16.0 | 15.0 | 31.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 206 | 2020-12-29 | Pfizer/BioNTech | LOM | 40-49 | 10.0 | 18.0 | 28.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 207 | 2020-12-29 | Pfizer/BioNTech | LOM | 50-59 | 9.0 | 16.0 | 25.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 208 | 2020-12-29 | Pfizer/BioNTech | LOM | 60-69 | 8.0 | 4.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 209 | 2020-12-29 | Pfizer/BioNTech | PUG | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 210 | 2020-12-29 | Pfizer/BioNTech | SAR | 20-29 | 2.0 | 2.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 211 | 2020-12-29 | Pfizer/BioNTech | SAR | 30-39 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 212 | 2020-12-29 | Pfizer/BioNTech | SAR | 40-49 | 7.0 | 5.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 213 | 2020-12-29 | Pfizer/BioNTech | SAR | 50-59 | 10.0 | 11.0 | 21.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 214 | 2020-12-29 | Pfizer/BioNTech | SAR | 60-69 | 12.0 | 5.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 215 | 2020-12-29 | Pfizer/BioNTech | SIC | 20-29 | 12.0 | 8.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 216 | 2020-12-29 | Pfizer/BioNTech | SIC | 30-39 | 34.0 | 35.0 | 68.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 217 | 2020-12-29 | Pfizer/BioNTech | SIC | 40-49 | 44.0 | 28.0 | 72.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 218 | 2020-12-29 | Pfizer/BioNTech | SIC | 50-59 | 40.0 | 26.0 | 66.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 219 | 2020-12-29 | Pfizer/BioNTech | SIC | 60-69 | 55.0 | 17.0 | 72.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 220 | 2020-12-29 | Pfizer/BioNTech | TOS | 40-49 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 221 | 2020-12-30 | Moderna | FVG | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 222 | 2020-12-30 | Moderna | FVG | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 223 | 2020-12-30 | Moderna | FVG | 30-39 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 224 | 2020-12-30 | Moderna | FVG | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 225 | 2020-12-30 | Moderna | LAZ | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 226 | 2020-12-30 | Moderna | LAZ | 30-39 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 227 | 2020-12-30 | Moderna | LAZ | 40-49 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 228 | 2020-12-30 | Moderna | LAZ | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 229 | 2020-12-30 | Pfizer/BioNTech | EMR | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 230 | 2020-12-30 | Pfizer/BioNTech | EMR | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 231 | 2020-12-30 | Pfizer/BioNTech | FVG | 20-29 | 18.0 | 33.0 | 51.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 232 | 2020-12-30 | Pfizer/BioNTech | FVG | 30-39 | 55.0 | 82.0 | 137.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 233 | 2020-12-30 | Pfizer/BioNTech | FVG | 40-49 | 46.0 | 119.0 | 165.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 234 | 2020-12-30 | Pfizer/BioNTech | FVG | 50-59 | 60.0 | 110.0 | 170.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 235 | 2020-12-30 | Pfizer/BioNTech | FVG | 60-69 | 54.0 | 40.0 | 94.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 236 | 2020-12-30 | Pfizer/BioNTech | FVG | 70-79 | 13.0 | 2.0 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 237 | 2020-12-30 | Pfizer/BioNTech | FVG | 80-89 | 2.0 | 1.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 238 | 2020-12-30 | Pfizer/BioNTech | LAZ | 20-29 | 58.0 | 90.0 | 148.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 239 | 2020-12-30 | Pfizer/BioNTech | LAZ | 30-39 | 122.0 | 211.0 | 333.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 240 | 2020-12-30 | Pfizer/BioNTech | LAZ | 40-49 | 148.0 | 300.0 | 448.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 241 | 2020-12-30 | Pfizer/BioNTech | LAZ | 50-59 | 158.0 | 284.0 | 442.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 242 | 2020-12-30 | Pfizer/BioNTech | LAZ | 60-69 | 131.0 | 86.0 | 217.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 243 | 2020-12-30 | Pfizer/BioNTech | LAZ | 70-79 | 17.0 | 16.0 | 33.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 244 | 2020-12-30 | Pfizer/BioNTech | LAZ | 80-89 | 6.0 | 23.0 | 29.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 245 | 2020-12-30 | Pfizer/BioNTech | LAZ | 90+ | 1.0 | 12.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 246 | 2020-12-30 | Pfizer/BioNTech | LIG | 20-29 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 247 | 2020-12-30 | Pfizer/BioNTech | LIG | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 248 | 2020-12-30 | Pfizer/BioNTech | LIG | 40-49 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 249 | 2020-12-30 | Pfizer/BioNTech | LIG | 50-59 | 4.0 | 3.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 250 | 2020-12-30 | Pfizer/BioNTech | LIG | 60-69 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 251 | 2020-12-30 | Pfizer/BioNTech | LOM | 20-29 | 3.0 | 9.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 252 | 2020-12-30 | Pfizer/BioNTech | LOM | 30-39 | 11.0 | 25.0 | 36.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 253 | 2020-12-30 | Pfizer/BioNTech | LOM | 40-49 | 10.0 | 16.0 | 26.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 254 | 2020-12-30 | Pfizer/BioNTech | LOM | 50-59 | 13.0 | 21.0 | 34.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 255 | 2020-12-30 | Pfizer/BioNTech | LOM | 60-69 | 4.0 | 2.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 256 | 2020-12-30 | Pfizer/BioNTech | LOM | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 257 | 2020-12-30 | Pfizer/BioNTech | MAR | 20-29 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 258 | 2020-12-30 | Pfizer/BioNTech | MAR | 30-39 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 259 | 2020-12-30 | Pfizer/BioNTech | MAR | 40-49 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 260 | 2020-12-30 | Pfizer/BioNTech | MAR | 50-59 | 2.0 | 6.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 261 | 2020-12-30 | Pfizer/BioNTech | MAR | 60-69 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 262 | 2020-12-30 | Pfizer/BioNTech | PAB | 20-29 | 22.0 | 33.0 | 54.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 263 | 2020-12-30 | Pfizer/BioNTech | PAB | 30-39 | 36.0 | 31.0 | 66.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 264 | 2020-12-30 | Pfizer/BioNTech | PAB | 40-49 | 55.0 | 88.0 | 143.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 265 | 2020-12-30 | Pfizer/BioNTech | PAB | 50-59 | 54.0 | 50.0 | 104.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 266 | 2020-12-30 | Pfizer/BioNTech | PAB | 60-69 | 29.0 | 12.0 | 41.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 267 | 2020-12-30 | Pfizer/BioNTech | PAB | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 268 | 2020-12-30 | Pfizer/BioNTech | PAT | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 269 | 2020-12-30 | Pfizer/BioNTech | PAT | 50-59 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 270 | 2020-12-30 | Pfizer/BioNTech | PAT | 60-69 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 271 | 2020-12-30 | Pfizer/BioNTech | PAT | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 272 | 2020-12-30 | Pfizer/BioNTech | PAT | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 273 | 2020-12-30 | Pfizer/BioNTech | PAT | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 274 | 2020-12-30 | Pfizer/BioNTech | PIE | 20-29 | 49.0 | 84.0 | 133.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 275 | 2020-12-30 | Pfizer/BioNTech | PIE | 30-39 | 65.0 | 44.0 | 109.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 276 | 2020-12-30 | Pfizer/BioNTech | PIE | 40-49 | 79.0 | 108.0 | 187.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 277 | 2020-12-30 | Pfizer/BioNTech | PIE | 50-59 | 80.0 | 145.0 | 225.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 278 | 2020-12-30 | Pfizer/BioNTech | PIE | 60-69 | 56.0 | 47.0 | 103.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 279 | 2020-12-30 | Pfizer/BioNTech | PUG | 40-49 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 280 | 2020-12-30 | Pfizer/BioNTech | SIC | 20-29 | 15.0 | 12.0 | 27.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 281 | 2020-12-30 | Pfizer/BioNTech | SIC | 30-39 | 32.0 | 31.0 | 63.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 282 | 2020-12-30 | Pfizer/BioNTech | SIC | 40-49 | 29.0 | 21.0 | 50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 283 | 2020-12-30 | Pfizer/BioNTech | SIC | 50-59 | 41.0 | 14.0 | 55.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 284 | 2020-12-30 | Pfizer/BioNTech | SIC | 60-69 | 24.0 | 14.0 | 38.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 285 | 2020-12-30 | Pfizer/BioNTech | TOS | 12-19 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 286 | 2020-12-30 | Pfizer/BioNTech | TOS | 20-29 | 9.0 | 3.0 | 12.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 287 | 2020-12-30 | Pfizer/BioNTech | TOS | 30-39 | 7.0 | 9.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 288 | 2020-12-30 | Pfizer/BioNTech | TOS | 40-49 | 5.0 | 18.0 | 22.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 289 | 2020-12-30 | Pfizer/BioNTech | TOS | 50-59 | 15.0 | 20.0 | 35.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 290 | 2020-12-30 | Pfizer/BioNTech | TOS | 60-69 | 11.0 | 9.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 291 | 2020-12-30 | Pfizer/BioNTech | TOS | 70-79 | 20.0 | 16.0 | 36.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 292 | 2020-12-30 | Pfizer/BioNTech | TOS | 80-89 | 24.0 | 84.0 | 108.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 293 | 2020-12-30 | Pfizer/BioNTech | TOS | 90+ | 11.0 | 65.0 | 76.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 294 | 2020-12-30 | Pfizer/BioNTech | VEN | 20-29 | 14.0 | 38.0 | 47.0 | 0.0 | 5.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 295 | 2020-12-30 | Pfizer/BioNTech | VEN | 30-39 | 46.0 | 76.0 | 115.0 | 0.0 | 7.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 296 | 2020-12-30 | Pfizer/BioNTech | VEN | 40-49 | 57.0 | 144.0 | 195.0 | 0.0 | 6.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 297 | 2020-12-30 | Pfizer/BioNTech | VEN | 50-59 | 66.0 | 150.0 | 212.0 | 0.0 | 4.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 298 | 2020-12-30 | Pfizer/BioNTech | VEN | 60-69 | 46.0 | 27.0 | 72.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 299 | 2020-12-30 | Pfizer/BioNTech | VEN | 70-79 | 4.0 | 4.0 | 8.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 300 | 2020-12-30 | Pfizer/BioNTech | VEN | 80-89 | 10.0 | 10.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 301 | 2020-12-30 | Pfizer/BioNTech | VEN | 90+ | 2.0 | 5.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 302 | 2020-12-31 | Pfizer/BioNTech | CAM | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 303 | 2020-12-31 | Pfizer/BioNTech | CAM | 20-29 | 48.0 | 78.0 | 126.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 304 | 2020-12-31 | Pfizer/BioNTech | CAM | 30-39 | 127.0 | 147.0 | 274.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 305 | 2020-12-31 | Pfizer/BioNTech | CAM | 40-49 | 171.0 | 182.0 | 352.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 306 | 2020-12-31 | Pfizer/BioNTech | CAM | 50-59 | 231.0 | 191.0 | 421.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 307 | 2020-12-31 | Pfizer/BioNTech | CAM | 60-69 | 229.0 | 79.0 | 307.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 308 | 2020-12-31 | Pfizer/BioNTech | CAM | 70-79 | 3.0 | 2.0 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 309 | 2020-12-31 | Pfizer/BioNTech | CAM | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF3 | 15.0 | Campania |
| 310 | 2020-12-31 | Pfizer/BioNTech | EMR | 20-29 | 67.0 | 174.0 | 241.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 311 | 2020-12-31 | Pfizer/BioNTech | EMR | 30-39 | 174.0 | 231.0 | 405.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 312 | 2020-12-31 | Pfizer/BioNTech | EMR | 40-49 | 151.0 | 311.0 | 460.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 313 | 2020-12-31 | Pfizer/BioNTech | EMR | 50-59 | 146.0 | 353.0 | 498.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 314 | 2020-12-31 | Pfizer/BioNTech | EMR | 60-69 | 183.0 | 115.0 | 298.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 315 | 2020-12-31 | Pfizer/BioNTech | EMR | 70-79 | 21.0 | 34.0 | 54.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 316 | 2020-12-31 | Pfizer/BioNTech | EMR | 80-89 | 25.0 | 121.0 | 144.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 317 | 2020-12-31 | Pfizer/BioNTech | EMR | 90+ | 15.0 | 102.0 | 116.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH5 | 8.0 | Emilia-Romagna |
| 318 | 2020-12-31 | Pfizer/BioNTech | FVG | 20-29 | 38.0 | 86.0 | 123.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 319 | 2020-12-31 | Pfizer/BioNTech | FVG | 30-39 | 90.0 | 133.0 | 223.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 320 | 2020-12-31 | Pfizer/BioNTech | FVG | 40-49 | 73.0 | 179.0 | 252.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 321 | 2020-12-31 | Pfizer/BioNTech | FVG | 50-59 | 83.0 | 212.0 | 295.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 322 | 2020-12-31 | Pfizer/BioNTech | FVG | 60-69 | 85.0 | 63.0 | 148.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 323 | 2020-12-31 | Pfizer/BioNTech | FVG | 70-79 | 15.0 | 2.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 324 | 2020-12-31 | Pfizer/BioNTech | FVG | 80-89 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 325 | 2020-12-31 | Pfizer/BioNTech | FVG | 90+ | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH4 | 6.0 | Friuli-Venezia Giulia |
| 326 | 2020-12-31 | Pfizer/BioNTech | LAZ | 20-29 | 138.0 | 297.0 | 435.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 327 | 2020-12-31 | Pfizer/BioNTech | LAZ | 30-39 | 405.0 | 569.0 | 974.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 328 | 2020-12-31 | Pfizer/BioNTech | LAZ | 40-49 | 423.0 | 892.0 | 1313.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 329 | 2020-12-31 | Pfizer/BioNTech | LAZ | 50-59 | 571.0 | 980.0 | 1548.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 330 | 2020-12-31 | Pfizer/BioNTech | LAZ | 60-69 | 561.0 | 328.0 | 887.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 331 | 2020-12-31 | Pfizer/BioNTech | LAZ | 70-79 | 33.0 | 32.0 | 65.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 332 | 2020-12-31 | Pfizer/BioNTech | LAZ | 80-89 | 27.0 | 81.0 | 108.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 333 | 2020-12-31 | Pfizer/BioNTech | LAZ | 90+ | 6.0 | 57.0 | 63.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI4 | 12.0 | Lazio |
| 334 | 2020-12-31 | Pfizer/BioNTech | LIG | 20-29 | 19.0 | 54.0 | 73.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 335 | 2020-12-31 | Pfizer/BioNTech | LIG | 30-39 | 51.0 | 67.0 | 118.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 336 | 2020-12-31 | Pfizer/BioNTech | LIG | 40-49 | 39.0 | 129.0 | 168.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 337 | 2020-12-31 | Pfizer/BioNTech | LIG | 50-59 | 103.0 | 214.0 | 317.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 338 | 2020-12-31 | Pfizer/BioNTech | LIG | 60-69 | 93.0 | 49.0 | 141.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 339 | 2020-12-31 | Pfizer/BioNTech | LIG | 70-79 | 24.0 | 24.0 | 48.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 340 | 2020-12-31 | Pfizer/BioNTech | LIG | 80-89 | 15.0 | 58.0 | 73.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 341 | 2020-12-31 | Pfizer/BioNTech | LIG | 90+ | 8.0 | 43.0 | 51.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC3 | 7.0 | Liguria |
| 342 | 2020-12-31 | Pfizer/BioNTech | LOM | 20-29 | 23.0 | 36.0 | 59.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 343 | 2020-12-31 | Pfizer/BioNTech | LOM | 30-39 | 76.0 | 84.0 | 160.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 344 | 2020-12-31 | Pfizer/BioNTech | LOM | 40-49 | 56.0 | 102.0 | 158.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 345 | 2020-12-31 | Pfizer/BioNTech | LOM | 50-59 | 88.0 | 161.0 | 249.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 346 | 2020-12-31 | Pfizer/BioNTech | LOM | 60-69 | 58.0 | 30.0 | 88.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 347 | 2020-12-31 | Pfizer/BioNTech | LOM | 70-79 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC4 | 3.0 | Lombardia |
| 348 | 2020-12-31 | Pfizer/BioNTech | MAR | 20-29 | 6.0 | 9.0 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 349 | 2020-12-31 | Pfizer/BioNTech | MAR | 30-39 | 36.0 | 42.0 | 78.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 350 | 2020-12-31 | Pfizer/BioNTech | MAR | 40-49 | 44.0 | 66.0 | 110.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 351 | 2020-12-31 | Pfizer/BioNTech | MAR | 50-59 | 40.0 | 58.0 | 98.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 352 | 2020-12-31 | Pfizer/BioNTech | MAR | 60-69 | 59.0 | 34.0 | 93.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI3 | 11.0 | Marche |
| 353 | 2020-12-31 | Pfizer/BioNTech | PAB | 12-19 | 9.0 | 5.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 354 | 2020-12-31 | Pfizer/BioNTech | PAB | 20-29 | 66.0 | 55.0 | 121.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 355 | 2020-12-31 | Pfizer/BioNTech | PAB | 30-39 | 94.0 | 68.0 | 162.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 356 | 2020-12-31 | Pfizer/BioNTech | PAB | 40-49 | 123.0 | 103.0 | 225.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 357 | 2020-12-31 | Pfizer/BioNTech | PAB | 50-59 | 144.0 | 140.0 | 283.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 358 | 2020-12-31 | Pfizer/BioNTech | PAB | 60-69 | 81.0 | 29.0 | 110.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 359 | 2020-12-31 | Pfizer/BioNTech | PAB | 70-79 | 13.0 | 2.0 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 360 | 2020-12-31 | Pfizer/BioNTech | PAB | 80-89 | 1.0 | 1.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH1 | 4.0 | Provincia Autonoma Bolzano / Bozen |
| 361 | 2020-12-31 | Pfizer/BioNTech | PAT | 12-19 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 362 | 2020-12-31 | Pfizer/BioNTech | PAT | 20-29 | 32.0 | 92.0 | 124.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 363 | 2020-12-31 | Pfizer/BioNTech | PAT | 30-39 | 68.0 | 123.0 | 191.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 364 | 2020-12-31 | Pfizer/BioNTech | PAT | 40-49 | 55.0 | 216.0 | 271.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 365 | 2020-12-31 | Pfizer/BioNTech | PAT | 50-59 | 92.0 | 257.0 | 349.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 366 | 2020-12-31 | Pfizer/BioNTech | PAT | 60-69 | 81.0 | 86.0 | 167.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 367 | 2020-12-31 | Pfizer/BioNTech | PAT | 70-79 | 61.0 | 77.0 | 138.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 368 | 2020-12-31 | Pfizer/BioNTech | PAT | 80-89 | 76.0 | 204.0 | 279.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 369 | 2020-12-31 | Pfizer/BioNTech | PAT | 90+ | 21.0 | 190.0 | 211.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH2 | 4.0 | Provincia Autonoma Trento |
| 370 | 2020-12-31 | Pfizer/BioNTech | PIE | 12-19 | 0.0 | 3.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 371 | 2020-12-31 | Pfizer/BioNTech | PIE | 20-29 | 119.0 | 251.0 | 369.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 372 | 2020-12-31 | Pfizer/BioNTech | PIE | 30-39 | 262.0 | 398.0 | 658.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 373 | 2020-12-31 | Pfizer/BioNTech | PIE | 40-49 | 264.0 | 700.0 | 963.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 374 | 2020-12-31 | Pfizer/BioNTech | PIE | 50-59 | 399.0 | 935.0 | 1331.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 375 | 2020-12-31 | Pfizer/BioNTech | PIE | 60-69 | 269.0 | 231.0 | 500.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 376 | 2020-12-31 | Pfizer/BioNTech | PIE | 70-79 | 19.0 | 16.0 | 35.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 377 | 2020-12-31 | Pfizer/BioNTech | PIE | 80-89 | 22.0 | 35.0 | 57.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 378 | 2020-12-31 | Pfizer/BioNTech | PIE | 90+ | 4.0 | 36.0 | 40.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC1 | 1.0 | Piemonte |
| 379 | 2020-12-31 | Pfizer/BioNTech | PUG | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 380 | 2020-12-31 | Pfizer/BioNTech | PUG | 20-29 | 72.0 | 132.0 | 204.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 381 | 2020-12-31 | Pfizer/BioNTech | PUG | 30-39 | 167.0 | 194.0 | 361.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 382 | 2020-12-31 | Pfizer/BioNTech | PUG | 40-49 | 190.0 | 232.0 | 422.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 383 | 2020-12-31 | Pfizer/BioNTech | PUG | 50-59 | 213.0 | 199.0 | 410.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 384 | 2020-12-31 | Pfizer/BioNTech | PUG | 60-69 | 130.0 | 65.0 | 195.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 385 | 2020-12-31 | Pfizer/BioNTech | PUG | 70-79 | 6.0 | 10.0 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 386 | 2020-12-31 | Pfizer/BioNTech | PUG | 80-89 | 8.0 | 11.0 | 19.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 387 | 2020-12-31 | Pfizer/BioNTech | PUG | 90+ | 0.0 | 10.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITF | ITF4 | 16.0 | Puglia |
| 388 | 2020-12-31 | Pfizer/BioNTech | SAR | 30-39 | 1.0 | 3.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 389 | 2020-12-31 | Pfizer/BioNTech | SAR | 40-49 | 3.0 | 3.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 390 | 2020-12-31 | Pfizer/BioNTech | SAR | 50-59 | 8.0 | 12.0 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 391 | 2020-12-31 | Pfizer/BioNTech | SAR | 60-69 | 8.0 | 1.0 | 9.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 392 | 2020-12-31 | Pfizer/BioNTech | SAR | 70-79 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG2 | 20.0 | Sardegna |
| 393 | 2020-12-31 | Pfizer/BioNTech | SIC | 12-19 | 2.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 394 | 2020-12-31 | Pfizer/BioNTech | SIC | 20-29 | 72.0 | 94.0 | 166.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 395 | 2020-12-31 | Pfizer/BioNTech | SIC | 30-39 | 87.0 | 93.0 | 179.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 396 | 2020-12-31 | Pfizer/BioNTech | SIC | 40-49 | 117.0 | 119.0 | 236.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 397 | 2020-12-31 | Pfizer/BioNTech | SIC | 50-59 | 147.0 | 116.0 | 263.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 398 | 2020-12-31 | Pfizer/BioNTech | SIC | 60-69 | 97.0 | 51.0 | 148.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 399 | 2020-12-31 | Pfizer/BioNTech | SIC | 70-79 | 6.0 | 0.0 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITG | ITG1 | 19.0 | Sicilia |
| 400 | 2020-12-31 | Pfizer/BioNTech | TOS | 20-29 | 5.0 | 12.0 | 17.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 401 | 2020-12-31 | Pfizer/BioNTech | TOS | 30-39 | 11.0 | 16.0 | 27.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 402 | 2020-12-31 | Pfizer/BioNTech | TOS | 40-49 | 8.0 | 25.0 | 33.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 403 | 2020-12-31 | Pfizer/BioNTech | TOS | 50-59 | 19.0 | 40.0 | 58.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 404 | 2020-12-31 | Pfizer/BioNTech | TOS | 60-69 | 25.0 | 47.0 | 72.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 405 | 2020-12-31 | Pfizer/BioNTech | TOS | 70-79 | 48.0 | 86.0 | 133.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 406 | 2020-12-31 | Pfizer/BioNTech | TOS | 80-89 | 60.0 | 198.0 | 258.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 407 | 2020-12-31 | Pfizer/BioNTech | TOS | 90+ | 26.0 | 179.0 | 203.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | ITI | ITI1 | 9.0 | Toscana |
| 408 | 2020-12-31 | Pfizer/BioNTech | UMB | 20-29 | 9.0 | 18.0 | 27.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 409 | 2020-12-31 | Pfizer/BioNTech | UMB | 30-39 | 26.0 | 37.0 | 63.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 410 | 2020-12-31 | Pfizer/BioNTech | UMB | 40-49 | 30.0 | 70.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 411 | 2020-12-31 | Pfizer/BioNTech | UMB | 50-59 | 35.0 | 73.0 | 108.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 412 | 2020-12-31 | Pfizer/BioNTech | UMB | 60-69 | 36.0 | 13.0 | 49.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITI | ITI2 | 10.0 | Umbria |
| 413 | 2020-12-31 | Pfizer/BioNTech | VDA | 20-29 | 0.0 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 414 | 2020-12-31 | Pfizer/BioNTech | VDA | 30-39 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 415 | 2020-12-31 | Pfizer/BioNTech | VDA | 40-49 | 1.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 416 | 2020-12-31 | Pfizer/BioNTech | VDA | 50-59 | 3.0 | 7.0 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 417 | 2020-12-31 | Pfizer/BioNTech | VDA | 60-69 | 0.0 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITC | ITC2 | 2.0 | Valle d'Aosta / Vallée d'Aoste |
| 418 | 2020-12-31 | Pfizer/BioNTech | VEN | 12-19 | 1.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 419 | 2020-12-31 | Pfizer/BioNTech | VEN | 20-29 | 93.0 | 256.0 | 309.0 | 0.0 | 40.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 420 | 2020-12-31 | Pfizer/BioNTech | VEN | 30-39 | 186.0 | 314.0 | 476.0 | 0.0 | 24.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 421 | 2020-12-31 | Pfizer/BioNTech | VEN | 40-49 | 201.0 | 563.0 | 740.0 | 0.0 | 24.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 422 | 2020-12-31 | Pfizer/BioNTech | VEN | 50-59 | 279.0 | 691.0 | 964.0 | 0.0 | 6.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 423 | 2020-12-31 | Pfizer/BioNTech | VEN | 60-69 | 234.0 | 162.0 | 393.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 424 | 2020-12-31 | Pfizer/BioNTech | VEN | 70-79 | 18.0 | 29.0 | 44.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 425 | 2020-12-31 | Pfizer/BioNTech | VEN | 80-89 | 24.0 | 74.0 | 97.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |
| 426 | 2020-12-31 | Pfizer/BioNTech | VEN | 90+ | 6.0 | 92.0 | 97.0 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | ITH | ITH3 | 5.0 | Veneto |